UBS AM’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.76M Buy
443,578
+284,431
+179% +$2.41M ﹤0.01% 1840
2025
Q1
$1.28M Sell
159,147
-204,527
-56% -$1.64M ﹤0.01% 2205
2024
Q4
$3.27M Buy
363,674
+65,220
+22% +$586K ﹤0.01% 1814
2024
Q3
$2.19M Sell
298,454
-27,428
-8% -$201K ﹤0.01% 1994
2024
Q2
$1.86M Buy
325,882
+165,734
+103% +$946K ﹤0.01% 2036
2024
Q1
$802K Hold
160,148
﹤0.01% 2114
2023
Q4
$1.44M Buy
160,148
+12,447
+8% +$112K ﹤0.01% 1835
2023
Q3
$1.15M Sell
147,701
-955
-0.6% -$7.42K ﹤0.01% 1883
2023
Q2
$1.63M Hold
148,656
﹤0.01% 1770
2023
Q1
$1.63M Buy
148,656
+6,277
+4% +$68.8K ﹤0.01% 1770
2022
Q4
$615K Buy
142,379
+51,569
+57% +$223K ﹤0.01% 2093
2022
Q3
$683K Sell
90,810
-9,030
-9% -$67.9K ﹤0.01% 2188
2022
Q2
$1M Buy
99,840
+47,100
+89% +$473K ﹤0.01% 1961
2022
Q1
$653K Sell
52,740
-88,719
-63% -$1.1M ﹤0.01% 2356
2021
Q4
$1.97M Buy
141,459
+129,178
+1,052% +$1.8M ﹤0.01% 1880
2021
Q3
$272K Sell
12,281
-129,178
-91% -$2.86M ﹤0.01% 2638
2021
Q2
$1.84M Buy
141,459
+21,300
+18% +$276K ﹤0.01% 1894
2021
Q1
$1.56M Buy
120,159
+8,200
+7% +$107K ﹤0.01% 1860
2020
Q4
$1.54M Buy
111,959
+12,700
+13% +$175K ﹤0.01% 1787
2020
Q3
$1.46M Buy
99,259
+19,900
+25% +$292K ﹤0.01% 1681
2020
Q2
$1.28M Buy
79,359
+5,900
+8% +$95.5K ﹤0.01% 1698
2020
Q1
$1.05M Buy
73,459
+18,200
+33% +$261K ﹤0.01% 1678
2019
Q4
$1.12M Buy
55,259
+38,800
+236% +$787K ﹤0.01% 1853
2019
Q3
$87.9K Buy
16,459
+3,159
+24% +$16.9K ﹤0.01% 2676
2019
Q2
$87.9K Buy
+13,300
New +$87.9K ﹤0.01% 2657